L'un des principaux objectifs de Life4me + - est de prévenir de nouveaux cas de VIH et d'autres IST, d'hépatite C et de tuberculose.

L'application aide à établir une communication anonyme entre les médecins et les personnes séropositives. Elle vous permet d'organiser facilement votre horaire de prise de médicaments et de définir des rappels cachés et personnalisés.

Toutes les actualités / Décembre 2016

Archive

✕

27 décembre 2016

7432

Cameroon: 50 people were convicted of homosexuality between 2010 and 2014

Cameroon: 50 people were convicted of homosexuality between 2010 and 2014

Cameroon is still prosecutes people for being gay more aggressively than almost any other nation in the world. According to data collected by The Cameroonian Foundation for AIDS, at least 50 people in Cameroon were convicted of homosexuality between 2010 and 2014 for acts ...

hivaids

26 décembre 2016

7363

Sweden, Denmark and Norway to increase their contribution to UNAIDS next year

Sweden, Denmark and Norway to increase their contribution to UNAIDS next year

UNAIDS has published a press release in which welcomes new funding commitments from 3 Nordic countries for 2017.

unaidshivaids

25 décembre 2016

6801

UK: 40% drop in new HIV infections

UK: 40% drop in new HIV infections

The largest sexual health clinic in the UK has reported a dramatic drop in the number of people they have diagnosed with HIV this year.

hivprep

22 décembre 2016

7263

Janssen Sciences: Investigational two-drug HIV regimen showed positive results

Janssen Sciences: Investigational two-drug HIV regimen showed positive results

Janssen Sciences Ireland UC (Janssen) announced the results from first phase III studies of investigational two-drug HIV treatment regimen. Two Phase III studies were designed to evaluate the safety and efficacy of switching virologically suppressed patients from a three ...

21 décembre 2016

7512

Study: Drugs for HIV and Hepatitis C treatment can cause side effects when used together

Study: Drugs for HIV and Hepatitis C treatment can cause side effects when used together

Study: Use of direct-acting antivirals for the treatment of Hepatitis C virus infection, which contain sofosbuvir can lead to Hepatitis B reactivation in the body, as well as to interact with HIV drug tenofovir disoproxil.

sofosbuvirhepatitishepatitis chiv

21 décembre 2016

8679

GSK to test injectable drug for PrEP

GSK to test injectable drug for PrEP

GlaxoSmithKline had started a large study to test an experimental long-acting injection for preventing of HIV infection. The drug cabotegravir, an injectable medication, which if effective might become an alternative to Truvada.

truvadacontraceptiongskprephivcabotegravirviiv

21 décembre 2016

7715

Study: Drugs for HIV and Hepatitis C treatment can cause side effects when used together

Study: Drugs for HIV and Hepatitis C treatment can cause side effects when used together

According to a study published by University of Rhode Island pharmacy professor and a graduate student in the Journal of Hepatology, use of direct-acting antivirals for the treatment of Hepatitis C virus infection , such as Sovaldi, Harvoni and Epclusa, which contain sofosbuvir ...

hepcsidehepatitishiv

20 décembre 2016

8361

Dolutegravir quickly reduces viral load in semen

Dolutegravir quickly reduces viral load in semen

According to the new study published in the Journal of Infectious Diseases, dolutegravir (Tivicay) is able to dramatically reduce the viral load in semen. Semen is thought to be a reservoir of the virus and other antiviral drugs have difficult time reaching this area. It ...

dolutegravirtivicayhiv

20 décembre 2016

7101

Study: sex-race health disparities in the occurrence of chronic diseases associated with ageing

Study: sex-race health disparities in the occurrence of chronic diseases associated with ageing

A group of researchers from the United States have published the results of a study regarding ART-treated people and sex-race disparities in the occurrence of chronic diseases associated with ageing. The study was published in the online edition of Clinical Infectious Diseases. ...

19 décembre 2016

6878

Ibalizumab might be the answer for patients with drug resistance

Ibalizumab might be the answer for patients with drug resistance

According to the results from a Phase 3 trial published in October, an experimental injectable drug, ibalizumab, might be an option for patients struggling with drug resistance. Drug resistant strains are now a major threat to effective HIV treatment worldwide. Patients ...

ibalizumabresistancehiv

1 2 3...5